ERBB2 and breast cancer: The normal breast-like and luminal-like subtypes are predominantly ER+/PR+; HER2 overexpressing breast cancers are predominantly ER−/PR− and the basal-like subtype, which is predominantly ER−/PR−/HER2−, also called triple-negative phenotype.